California Public Employees Retirement System increased its stake in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,851 shares of the company’s stock after purchasing an additional 1,051 shares during the period. California Public Employees Retirement System’s holdings in Taro Pharmaceutical Industries were worth $3,815,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Advisory Services Network LLC grew its stake in Taro Pharmaceutical Industries by 2.0% in the 2nd quarter. Advisory Services Network LLC now owns 5,474 shares of the company’s stock worth $613,000 after acquiring an additional 105 shares during the period. Russell Investments Group Ltd. grew its stake in Taro Pharmaceutical Industries by 7.4% in the 2nd quarter. Russell Investments Group Ltd. now owns 2,257 shares of the company’s stock worth $253,000 after acquiring an additional 156 shares during the period. Wells Fargo & Company MN grew its stake in Taro Pharmaceutical Industries by 11.2% in the 2nd quarter. Wells Fargo & Company MN now owns 1,685 shares of the company’s stock worth $189,000 after acquiring an additional 170 shares during the period. Legal & General Group Plc grew its stake in Taro Pharmaceutical Industries by 4.7% in the 2nd quarter. Legal & General Group Plc now owns 8,318 shares of the company’s stock worth $932,000 after acquiring an additional 370 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in Taro Pharmaceutical Industries by 1.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 30,502 shares of the company’s stock worth $3,438,000 after acquiring an additional 436 shares during the period. Hedge funds and other institutional investors own 13.44% of the company’s stock.

Separately, BidaskClub raised shares of Taro Pharmaceutical Industries from a “hold” rating to a “buy” rating in a research note on Thursday, September 28th.

Shares of Taro Pharmaceutical Industries Ltd. (TARO) opened at $105.10 on Friday. The company has a market cap of $4,170.00, a P/E ratio of 12.96 and a beta of 0.62. Taro Pharmaceutical Industries Ltd. has a 12 month low of $94.00 and a 12 month high of $128.46.

WARNING: “California Public Employees Retirement System Raises Position in Taro Pharmaceutical Industries Ltd. (TARO)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2018/01/12/california-public-employees-retirement-system-raises-position-in-taro-pharmaceutical-industries-ltd-taro.html.

Taro Pharmaceutical Industries Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Want to see what other hedge funds are holding TARO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taro Pharmaceutical Industries Ltd. (NYSE:TARO).

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.